Mr. Speaker, I listened with great interest to my hon. colleague and the points she raised in this important discussion on ensuring that we have the protocols in place to protect health in dealing with drugs that are being put on the market.
One of the questions that has been raised is the importance of public disclosure of clinical trial results. Currently the results of many clinical trials are never published or made publicly available in Canada. There has been a move to have these reports, good or bad, put out there so that patients, physicians, and researchers have all the information they need to deal with new drugs being put on the market.
In 2005, the World Health Organization stated its support for the requirement to register clinical trials, to develop worldwide standards for trial registration, and to encourage sponsors to make their data public. I would like to ask my hon. colleague what she thinks about the importance of making the clinical trial information on the drugs being prepared available to the public.